Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Indra Agarwal"'
Autor:
Massimo Imazio, Allan L. Klein, Antonio Brucato, Antonio Abbate, Michael Arad, Paul C. Cremer, Antonella Insalaco, Martin M. LeWinter, Basil S. Lewis, David Lin, Sushil A. Luis, Stephen J. Nicholls, Paul Sutej, Yishay Wasserstrum, JoAnn Clair, Indra Agarwal, Sheldon Wang, John F. Paolini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptom
Externí odkaz:
https://doaj.org/article/5b697727911f4cb89e0bb7e5b20b9221
Autor:
Xiaolei Zhou, Eric Davenport, John Ouyang, Molly E. Hoke, Diana Garbinsky, Indra Agarwal, Holly B. Krasa, Dorothee Oberdhan
Publikováno v:
Kidney International Reports. 7:1037-1048
In 1- and 3-year randomized trials, tolvaptan slowed kidney function decline in subjects with autosomal dominant polycystic kidney disease (ADPKD) at risk of rapid progression. The 3-year trial also evaluated effects on total kidney volume (TKV); slo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa6962b5e45ba1545889135f1b703fa
https://doi.org/10.1016/j.ekir.2022.02.009
https://doi.org/10.1016/j.ekir.2022.02.009
Autor:
John Ouyang, Xiaolei Zhou, Diana Garbinsky, Eric Davenport, Dorothee Oberdhan, Holly B. Krasa, Indra Agarwal
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and the fourth-leading cause of kidney failure. Over the past two decades, various studies have been conducted to characterize the n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42605230411b7bfdc59ae45e00766ef9
https://doi.org/10.1093/ndt/gfaa142.p0037
https://doi.org/10.1093/ndt/gfaa142.p0037
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims : Observation of impactful clinical outcomes in a clinical trial setting for ADPKD is challenging due to the life-long progressive nature of ADPKD and longer-term associated outcomes of interest in this population (e.g., renal fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::561206297d09562b9da9fbe19e6594f2
https://doi.org/10.1093/ndt/gfaa139.so093
https://doi.org/10.1093/ndt/gfaa139.so093
Autor:
Indra Agarwal, Diana Garbinsky, John Ouyang, Holly B. Krasa, Xiaolei Zhou, Dorothee Oberdhan, Eric Davenport
Publikováno v:
American Journal of Kidney Diseases. 75:663
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::421c7bc53584a421fd24c5daaa2d1718
https://doi.org/10.1053/j.ajkd.2020.02.434
https://doi.org/10.1053/j.ajkd.2020.02.434